Literature DB >> 19852756

Peroxisome-proliferator-activated receptor-binding protein (PBP) is essential for the growth of active Notch4-immortalized mammary epithelial cells by activating SOX10 expression.

Yiwei Tony Zhu1, Yuzhi Jia, Liping Hu, Chao Qi, Megana K Prasad, Andrew S McCallion, Yi-Jun Zhu.   

Abstract

PBP (peroxisome-proliferator-activated receptor-binding protein) [Med1 (mediator 1)/TRAP220 (thyroid-hormone-receptor-associated protein 220)] is essential for mammary gland development. We established a mammary epithelial cell line with a genotype of PBPLoxP/LoxP by expressing an active form of Notch4. Null mutation of PBP caused severe growth inhibition of the Notch4-immortalized mammary cells. We found that truncated PBP without the two LXXLL motifs could reverse the growth inhibition due to the deficiency of endogenous PBP, indicating that signalling through nuclear receptors is unlikely to be responsible for the growth inhibition as the result of PBP deficiency. Loss of PBP expression was shown to completely ablate the expression of SOX10 [Sry-related HMG (high-mobility group) box gene 10]. The re-expression of SOX10 was capable of reversing the growth inhibition due to PBP deficiency, whereas suppressed expression of SOX10 inhibited the growth of Notch4-immortalized mammary cells. Further studies revealed PBP is directly recruited to the enhancer of the SOX10 gene, indicating that SOX10 is a direct target gene of PBP. We conclude that PBP is essential for the growth of Notch4-immortalized mammary cells by activating SOX10 expression, providing a potential molecular mechanism through which PBP regulates the growth of mammary stem/progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19852756      PMCID: PMC3005363          DOI: 10.1042/BJ20091237

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action.

Authors:  M Ito; C X Yuan; H J Okano; R B Darnell; R G Roeder
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

2.  Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium.

Authors:  G H Smith; T Mehrel; D R Roop
Journal:  Cell Growth Differ       Date:  1990-04

3.  Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality.

Authors:  Y Zhu; C Qi; Y Jia; J S Nye; M S Rao; J K Reddy
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

4.  Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.

Authors:  A K Indra; X Warot; J Brocard; J M Bornert; J H Xiao; P Chambon; D Metzger
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

5.  Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors.

Authors:  Susan E Crawford; Chao Qi; Parimal Misra; Veronica Stellmach; M Sambasiva Rao; James D Engel; Yijun Zhu; Janardan K Reddy
Journal:  J Biol Chem       Date:  2001-11-27       Impact factor: 5.157

6.  Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma.

Authors:  M A Cifone; I J Fidler
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

7.  Sustained growth in primary culture of normal mammary epithelial cells embedded in collagen gels.

Authors:  J Yang; J Richards; R Guzman; W Imagawa; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

8.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

Review 9.  Notch in mammary gland development and breast cancer.

Authors:  Katerina Politi; Nikki Feirt; Jan Kitajewski
Journal:  Semin Cancer Biol       Date:  2004-10       Impact factor: 15.707

10.  Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.

Authors:  Yuzhi Jia; Chao Qi; Papreddy Kashireddi; Sailesh Surapureddi; Yi-Jun Zhu; M Sambasiva Rao; Derek Le Roith; Pierre Chambon; Frank J Gonzalez; Janardan K Reddy
Journal:  J Biol Chem       Date:  2004-03-29       Impact factor: 5.157

View more
  9 in total

Review 1.  Sox proteins in melanocyte development and melanoma.

Authors:  Melissa L Harris; Laura L Baxter; Stacie K Loftus; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-22       Impact factor: 4.693

Review 2.  Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.

Authors:  Gaurav A Mehta; Pooja Khanna; Michael L Gatza
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-09       Impact factor: 2.673

3.  Coactivators in PPAR-Regulated Gene Expression.

Authors:  Navin Viswakarma; Yuzhi Jia; Liang Bai; Aurore Vluggens; Jayme Borensztajn; Jianming Xu; Janardan K Reddy
Journal:  PPAR Res       Date:  2010-08-05       Impact factor: 4.964

4.  Mediator subunits MED1 and MED24 cooperatively contribute to pubertal mammary gland development and growth of breast carcinoma cells.

Authors:  Natsumi Hasegawa; Akiko Sumitomo; Azusa Fujita; Nami Aritome; Shumpei Mizuta; Keiji Matsui; Ruri Ishino; Kana Inoue; Norinaga Urahama; Junko Nose; Toru Mukohara; Shingo Kamoshida; Robert G Roeder; Mitsuhiro Ito
Journal:  Mol Cell Biol       Date:  2012-02-13       Impact factor: 4.272

5.  Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.

Authors:  Ashley Cimino-Mathews; Andrea P Subhawong; Hillary Elwood; Hind Nassar Warzecha; Rajni Sharma; Ben Ho Park; Janis M Taube; Peter B Illei; Pedram Argani
Journal:  Hum Pathol       Date:  2012-12-20       Impact factor: 3.466

6.  Clinicopathological, immunohistochemical and molecular correlation of neural crest transcription factor SOX10 expression in triple-negative breast carcinoma.

Authors:  Aparna Harbhajanka; Satyapal Chahar; Kristy Miskimen; Paula Silverman; Lyndsay Harris; Nicole Williams; Vinay Varadan; Hannah Gilmore
Journal:  Hum Pathol       Date:  2018-06-09       Impact factor: 3.466

7.  Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration.

Authors:  Xiao-Bin Lv; Wei Wu; Xiaofeng Tang; Yanqing Wu; Yinghua Zhu; Yujie Liu; Xiuying Cui; Junjun Chu; Pengnan Hu; Jingjing Li; Qiannan Guo; Zeming Cai; Juan Wu; Kaishun Hu; Nengyong Ouyang
Journal:  Oncotarget       Date:  2015-11-03

8.  A dual role for SOX10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitors.

Authors:  Melissa L Harris; Kristina Buac; Olga Shakhova; Ramin M Hakami; Michael Wegner; Lukas Sommer; William J Pavan
Journal:  PLoS Genet       Date:  2013-07-25       Impact factor: 5.917

9.  Clinicopathological significance of Sox10 expression in triple-negative breast carcinoma.

Authors:  Linfang Jin; Chenglin Qin; Xiaowei Qi; Tingting Hong; Xiaodong Yang; Xun Zhu
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.